Show simple item record

dc.contributor.authorCarlo-Stella, Cen_US
dc.contributor.authorCollins, GPen_US
dc.contributor.authorArmand, Pen_US
dc.contributor.authorZinzani, PLen_US
dc.contributor.authorCohen, JBen_US
dc.contributor.authorHalwani, Aen_US
dc.contributor.authorMillenson, Men_US
dc.contributor.authorProvencio, Men_US
dc.contributor.authorDomingo Domenech, Een_US
dc.contributor.authorGiulino-Roth, Len_US
dc.contributor.authorCastagna, Len_US
dc.contributor.authorKato, Ken_US
dc.contributor.authorMcKiver, MPen_US
dc.contributor.authorSumbul, Aen_US
dc.contributor.authorZhu, Len_US
dc.contributor.authorTrneny, Men_US
dc.contributor.authorMinnema, MCen_US
dc.contributor.authorRueda, Aen_US
dc.contributor.authorCunningham, Den_US
dc.contributor.authorReddy, Nen_US
dc.contributor.authorYounes, Aen_US
dc.contributor.authorSantoro, Aen_US
dc.date.accessioned2018-02-20T11:28:15Z
dc.date.issued2017-09-01en_US
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000558818800125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9en_US
dc.identifier.citationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 pp. S326 - S327 (2)en_US
dc.identifier.issn2152-2650en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1379
dc.identifier.eissn2152-2669en_US
dc.identifier.doi10.1016/j.clml.2017.07.136en_US
dc.format.extentS326 - S327 (2)en_US
dc.languageEnglishen_US
dc.language.isoEnglishen_US
dc.publisherCIG MEDIA GROUP, LPen_US
dc.subjectScience & Technologyen_US
dc.subjectLife Sciences & Biomedicineen_US
dc.subjectOncologyen_US
dc.subjectHematologyen_US
dc.titleAllogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205)en_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/j.clml.2017.07.136en_US
rioxxterms.licenseref.startdate2017-09-01en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfCLINICAL LYMPHOMA MYELOMA & LEUKEMIAen_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume17en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMedicine (RMH Smith Cunningham)en_US
dc.contributor.icrauthorMarsden,en_US
dc.contributor.icrauthorCunningham, Daviden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record